Cited by 13Antioxidant Activity and Oxidative StressBipolar Disorder and TreatmentTreatment of Major Depression

Antioxidant effect of simvastatin throught oxidative imbalance caused by lisdexamfetamine dimesylate

Open access
Eger, Guilherme A., Ferreira, Vinícius V., Batista, Camila R., Bonde, Henrique, Lima, Daniela D. de, Wyse, Angela T.S., Cruz, Júlia N. da, Rodrigues, André F. +2 more·2016·Anais da Academia Brasileira de Ciências

Abstract

The present study aims to directly investigate the behavioral and antioxidant effects of simvastatin in a model of bipolar mania induced by lisdexamfetamine dimesylate. Wistar rats were treated for 30 days with simvastatin. On the 24th day after the start of treatment, each rat was administered lisdexamfetamine dimesylate for 7 days. The results suggest that simvastatin combined with lisdexamfetamine dimesylate induced a significant increased locomotion and lisdexamfetamine dimesylate administration causes an oxidative imbalance determined by an increment in lipid peroxidation, protein oxidation and alterations in the activities of antioxidant enzymes in brain areas; moreover, in the presence of simvastatin, most of these effects were prevented. These findings contribute to a better understanding of the critical roles of lisdexamfetamine dimesylate in the treatment of neuropsychiatric disorders, associated with increased oxidative stress and changes in antioxidant enzymatic defense. In view of the central role played by lisdexamfetamine dimesylate, the established antioxidant effect of simvastatin therapy is of major interest.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1590/0001-3765201620140490

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Two studies have shown that the levels of these enzymes were decreased by LDX in neuropsychiatric disorder models.

    “In this sense, two studies have shown that the levels of these enzymes were decreased by LDX in neuropsychiatric disorder models [225, 226].”

    From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [225]

    The paper studies an LDX-induced rat model of bipolar mania. Its SOD assay discussion reports decreased CAT activity in the hippocampus and cerebral cortex and decreased SOD activity in the cerebellum. But it also reports increased SOD and GSH-Px activity in the hippocampus and cerebral cortex, so the unqualified claim that these enzymes decreased overstates its findings (page unavailable in our copy). (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • LDX increases the thiobarbituric acid-reactive substances in the cerebellum, hippocampus and cerebral cortex, although its MoA is unknown.

    “LDX increases the thiobarbituric acid-reactive substances in the cerebellum, hippocampus and cerebral cortex, although its MoA is unknown [225].”

    From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [225]

    The TBARS section reports that repeated LDX exposure increased TBARS in the cerebellum, hippocampus and cerebral cortex of rats. The discussion says the mechanisms responsible for LDX-induced oxidative stress have not been fully identified, but suggests dopamine metabolism and oxidation as a possible mechanism. Calling LDX’s mode of action simply “unknown” overstates that qualification. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • LDX causes oxidative imbalance through increased lipid peroxidation, protein oxidation and alterations in the activity of antioxidant enzymes in some brain areas.

    “LDX causes oxidative imbalance through increased lipid peroxidation, protein oxidation and alterations in the activity of antioxidant enzymes in some brain areas [225].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Eger, G. A., Ferreira, V. V., Batista, C. R., Bonde, H., Lima, D. D. D., Wyse, A. T. S., Cruz, J. N. D., Rodrigues, A. F., Magro, D. D. D., & Cruz, J. G. P. D.
Affiliations
  • Universidade Regional de Blumenau (BR)
  • Universidade da Região de Joinville (BR)
  • Universidade Federal do Rio Grande do Sul, Brasil
Venue
Anais da Academia Brasileira de Ciências
Published
2016-02-05
Volume
88
Issue
1
Pages
335-348
ISSN
  • 0001-3765 (ISSN-L)
  • 1678-2690
OpenAlex
W2324663504
Cited by
13
References
55
Citations by year
2025: 2 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 3 · 2018: 1 · 2017: 2
FWCI
0.78
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Anais da Academia Brasileira de Ciências (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
  • Americanae (AECID Library) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Redalyc (Universidad Autónoma del Estado de México) (submittedVersion)
Funders
  • Universidade Regional de Blumenau
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina
Topics
  • Health Sciences › Medicine › Biochemistry › Antioxidant Activity and Oxidative Stress
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
simvastatin, lisdexamfetamine dimesylate, oxidative stress, antioxidant enzymes, lipid peroxidation, protein oxidation, bipolar mania, locomotor activity, brain, statins
MeSH terms
Lisdexamfetamine Dimesylate, Central Nervous System Stimulants, Animals, Antioxidants, Behavior, Animal, Bipolar Disorder, Male, Lipid Peroxidation, Rats, Wistar, Oxidative Stress, Antimanic Agents, Simvastatin, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review